Welcome to Prism!

Upload scholarly work, create communities, get citable links and more. To get the most out of Prism, log in with your NetID and check out our guide.

COVID-19 Community
Published October 19, 2020 | Version v1.0.0
Other Article Open

Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response

De Souza, Andre1
Tavora, Fabio A.2
Mahalingam, Devalingam3
Munster, Pamela N.4
Safran, Howard P.1
El-Deiry, Wafik S.1
Carneiro, Benedito A.1
  • 1. ROR icon Brown University
  • 2. Argos Laboratory
  • 3. ROR icon Northwestern University
  • 4. ROR icon University of California, San Francisco

Other

original_citation: De Souza A, Tavora FA, Mahalingam D, Munster PN, Safran HP, El-Deiry WS, Carneiro BA. Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response. Frontiers in Immunology. 2020;11:3.

Files

fimmu-11-595289.pdf
Files (127.3 kB)
Name Size Download all
md5:ad0c89c2fc635e5dad597b9096d6cb2d
127.3 kB Preview Download

Additional details

Identifiers Related works Dates
Created:
March 30, 2023
Modified:
January 24, 2024